Trials / Not Yet Recruiting
Not Yet RecruitingNCT07312396
An Exploratory Clinical Study on the Protective Effect of Cycling on the Ankle Joint in Gout
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Zhu Xiaoxia · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study divided the enrolled gout patients into a jogging group and a cycling group to investigate 1)the effectiveness of cycling intervention in reducing the recurrence risk of gouty ankle arthritis compared with jogging. 2) To clarify the influence of different exercise patterns on the ultrasonic manifestations of gouty ankle arthritis; 3) Clarify the impact of different exercise methods on the blood uric acid levels of gout patients;
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Urate-lowering therapy (ULT) | The treatment with uric acid-lowering drugs remained the same as the standard uric acid-lowering treatment plan at the time of enrollment |
| BEHAVIORAL | Jogging | Participants in the study could exercise on the treadmills in the fitness center or jog outdoors, but both needed to reach a moderate intensity. Each total exercise session lasts between 45 and 60 minutes (including 5 to 10 minutes of warm-up time, no less than 20 minutes of exercise time reaching 65% to 75% of the maximum heart rate, and 10 to 15 minutes of cool-down exercise/muscle stretching time). |
| BEHAVIORAL | Cycling | Participants in the study could use the cycling equipment at the fitness center for exercise or do cycling outdoors, but both needed to reach a moderate intensity. Each total exercise session lasts between 45 and 60 minutes (including 5 to 10 minutes of warm-up time, no less than 20 minutes of exercise time reaching 65% to 75% of the maximum heart rate, and 10 to 15 minutes of cool-down exercise/muscle stretching time). |
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2027-11-30
- Completion
- 2027-12-30
- First posted
- 2025-12-31
- Last updated
- 2025-12-31
Source: ClinicalTrials.gov record NCT07312396. Inclusion in this directory is not an endorsement.